Kyowa Hakko Kirin Launches Nouriast For Parkinson’s Disease
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin announced May 29 it will launch Nouriast (istradefylline), a new mechanism of treatment for Parkinson’s disease, in Japan.